Biota Pharmaceuticals intends to price public offering of common stock

Guggenheim Securities is the bookrunner; proceeds fund working capital

By Devika Patel

Knoxville, Tenn., Jan. 9 - Biota Pharmaceuticals, Inc. said it will price a public offering of common stock.

Guggenheim Securities, LLC is the sole bookrunning manager.

Proceeds will be used for working capital and general corporate purposes.

The biopharmaceutical company is based in Alpharetta, Ga.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.